CASTLE BIOSCIENCES INC has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are XIAMEN SPACEGEN CO LTD, BOREAL GENOMICS INC and SHANGHAI SHINES PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | Israel | 1 | |
#8 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Combinatorial chemistry | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Maetzold Derek | 18 |
#2 | Cook Robert Willis | 17 |
#3 | Oeschlager Kristen | 11 |
#4 | Covington Kyle R | 4 |
#5 | Shan Weiwei | 3 |
#6 | Robert Willis Cook | 2 |
#7 | Derek Maetzold | 2 |
#8 | Cook Robert | 1 |
#9 | Kyle R Covington | 1 |
#10 | Kristen Oeschlager | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019213321A1 | Methods of diagnosing and treating patients with cutaneous squamous cell carcinoma | |
CA3098152A1 | Methods of diagnosing and treating patients with cutaneous squamous cell carcinoma | |
WO2017210662A1 | Methods for predicting risk of recurrence and/or metastasis in soft tissue sarcoma | |
AU2014241995A1 | Methods for predicting risk of metastasis in cutaneous melanoma |